MICHAEL RAAB

CIK 1321402 · President & CEO · last filed 2026-05-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10.11M

Companies

4

Total Filings

120

Lifetime Open-Market Net

-$8.75M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ARDX President & CEO 1,776,351 $5.69 $10.11M -$8.12M 83 2026-05-22
AMICUS THERAPEUTICS, INC. (FOLD) Delisted Director 0 $14.49 $0 -$629.0K 28 2026-04-27
TPST Director $1.26 $0 6 2026-01-28
Paratek Pharmaceuticals, Inc. (NOVC) Delisted Director $0 3 2008-03-31

Recent Filings · Page 11 of 12

120 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-01-23 ARDX Grant (A) +17,985 $0 EDGAR
2016-06-13 AMICUS THERAPEUTICS, INC. (FOLD) Delisted Grant (A) $0 EDGAR
2016-01-20 ARDX Grant (A) $0 EDGAR
2015-09-10 ARDX Sell (S) −9,785 -$198.5K EDGAR
2015-08-27 ARDX Sell (S) −1,104 -$22.1K EDGAR
2015-08-04 ARDX Sell (S) −300 -$6.0K EDGAR
2015-07-30 ARDX Sell (S) −2,111 -$42.2K EDGAR
2015-06-12 AMICUS THERAPEUTICS, INC. (FOLD) Delisted Grant (A) $0 EDGAR
2015-06-09 AMICUS THERAPEUTICS, INC. (FOLD) Delisted Disp (D) −8,936 -$113.0K EDGAR
2015-03-12 ARDX Other (J) +27 $0 EDGAR
Showing 101110 of 120
Page 11 of 12
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.